These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 9631524)
1. Purification and biochemical properties of soluble recombinant human Bax. Lewis S; Bethell SS; Patel S; Martinou JC; Antonsson B Protein Expr Purif; 1998 Jun; 13(1):120-6. PubMed ID: 9631524 [TBL] [Abstract][Full Text] [Related]
2. Expression and purification of full-length human Bax alpha. Montessuit S; Mazzei G; Magnenat E; Antonsson B Protein Expr Purif; 1999 Mar; 15(2):202-6. PubMed ID: 10049676 [TBL] [Abstract][Full Text] [Related]
4. Characterization of Bax-sigma, a cell death-inducing isoform of Bax. Schmitt E; Paquet C; Beauchemin M; Dever-Bertrand J; Bertrand R Biochem Biophys Res Commun; 2000 Apr; 270(3):868-79. PubMed ID: 10772918 [TBL] [Abstract][Full Text] [Related]
5. Refolding, purification, and characterization of a loop deletion mutant of human Bcl-2 from bacterial inclusion bodies. Anderson M; Blowers D; Hewitt N; Hedge P; Breeze A; Hampton I; Taylor I Protein Expr Purif; 1999 Mar; 15(2):162-70. PubMed ID: 10049671 [TBL] [Abstract][Full Text] [Related]
6. High-yield expression and purification of p18 form of Bax as an MBP-fusion protein. Eliseev R; Alexandrov A; Gunter T Protein Expr Purif; 2004 Jun; 35(2):206-9. PubMed ID: 15135394 [TBL] [Abstract][Full Text] [Related]
7. Bcl-xES, a BH4- and BH2-containing antiapoptotic protein, delays Bax oligomer formation and binds Apaf-1, blocking procaspase-9 activation. Schmitt E; Paquet C; Beauchemin M; Bertrand R Oncogene; 2004 May; 23(22):3915-31. PubMed ID: 15048082 [TBL] [Abstract][Full Text] [Related]
8. High-yield expression and purification of soluble forms of the anti-apoptotic Bcl-x(L) and Bcl-2 as TolAIII-fusion proteins. Nedelkina S; Gokce I; Ridley H; Weckerle C; Magnin T; Vallette F; Pattus F; Lakey JH; Bechinger B Protein Expr Purif; 2008 Aug; 60(2):214-20. PubMed ID: 18522870 [TBL] [Abstract][Full Text] [Related]
9. Interaction of E1B 19K with Bax is required to block Bax-induced loss of mitochondrial membrane potential and apoptosis. Han J; Modha D; White E Oncogene; 1998 Dec; 17(23):2993-3005. PubMed ID: 9881701 [TBL] [Abstract][Full Text] [Related]
10. Investigation of the role of the C-terminus of Bax and of tc-Bid on Bax interaction with yeast mitochondria. Priault M; Cartron PF; Camougrand N; Antonsson B; Vallette FM; Manon S Cell Death Differ; 2003 Sep; 10(9):1068-77. PubMed ID: 12934081 [TBL] [Abstract][Full Text] [Related]
11. Penicillin-binding protein 2a of Streptococcus pneumoniae: expression in Escherichia coli and purification and refolding of inclusion bodies into a soluble and enzymatically active enzyme. Zhao G; Meier TI; Hoskins J; Jaskunas SR Protein Expr Purif; 1999 Jul; 16(2):331-9. PubMed ID: 10419829 [TBL] [Abstract][Full Text] [Related]
12. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Datta SR; Katsov A; Hu L; Petros A; Fesik SW; Yaffe MB; Greenberg ME Mol Cell; 2000 Jul; 6(1):41-51. PubMed ID: 10949026 [TBL] [Abstract][Full Text] [Related]
13. Highly efficient protein expression and purification using bacterial hemoglobin fusion vector. Kwon SY; Choi YJ; Kang TH; Lee KH; Cha SS; Kim GH; Lee HS; Kim KT; Kim KJ Plasmid; 2005 May; 53(3):274-82. PubMed ID: 15848232 [TBL] [Abstract][Full Text] [Related]
14. Bfk: a novel weakly proapoptotic member of the Bcl-2 protein family with a BH3 and a BH2 region. Coultas L; Pellegrini M; Visvader JE; Lindeman GJ; Chen L; Adams JM; Huang DC; Strasser A Cell Death Differ; 2003 Feb; 10(2):185-92. PubMed ID: 12700646 [TBL] [Abstract][Full Text] [Related]
15. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. Zha H; Aimé-Sempé C; Sato T; Reed JC J Biol Chem; 1996 Mar; 271(13):7440-4. PubMed ID: 8631771 [TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of recombinant forms of murine Tcl1 proteins. Du Bois GC; Song SP; Kulikovskaya I; Rothstein JL; Germann MW; Croce CM Protein Expr Purif; 2000 Apr; 18(3):277-85. PubMed ID: 10733880 [TBL] [Abstract][Full Text] [Related]
17. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Chipuk JE; Kuwana T; Bouchier-Hayes L; Droin NM; Newmeyer DD; Schuler M; Green DR Science; 2004 Feb; 303(5660):1010-4. PubMed ID: 14963330 [TBL] [Abstract][Full Text] [Related]
18. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release. Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926 [TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions. Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412 [TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis transmembrane conductance regulator: the purified NBF1+R protein interacts with the purified NBF2 domain to form a stable NBF1+R/NBF2 complex while inducing a conformational change transmitted to the C-terminal region. Lu NT; Pedersen PL Arch Biochem Biophys; 2000 Mar; 375(1):7-20. PubMed ID: 10683244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]